Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

NCT00577850 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteopenia
Osteoporosis

Interventions

DRUG: risedronate
DRUG: alendronate

Sponsor

Warner Chilcott

Collaborators

[object Object]